Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 23 June 2009
Vol. 2, Issue 76, p. ra30
[DOI: 10.1126/scisignal.2000046]


Editor's Summary

Degrading the Gatekeeper
Full activation of T cells in vivo requires the simultaneous delivery of two independent signals: stimulation of the T cell receptor (TCR) by antigenic peptide presented by the major histocompatibility complex and stimulation of CD28 co-receptors. Stimulation of the TCR in the absence of a costimulatory signal results in a state of nonresponsiveness known as anergy, which is an important means of inhibiting the responses of self-reactive T cells that would otherwise trigger autoimmunity. The E3 ubiquitin ligase Cbl-b acts as a gatekeeper that prevents full activation of T cells by targeting proteins involved in TCR signaling for degradation (see the Perspective by Schmitz). Loss of cblb results in exacerbated autoimmune responses and enables activation of T cells through the TCR in the absence of costimulation of CD28. Cbl-b is itself targeted for ubiquitination and degradation in response to costimulation of CD28, but the mechanism involved is unclear. Gruber et al. found that protein kinase C-{theta} (PKC-{theta}), which is required for normal T cell immune responses, bound to Cbl-b on costimulation of CD28 and that PKC-{theta}–mediated phosphorylation of Cbl-b led to its ubiquitination and degradation. Experiments in which autoimmune disease was induced in mice singly or doubly deficient in cblb and PKC{theta} showed the antagonistic functions of Cbl-b and PKC-{theta} in regulating activation of T cells. Together, these data suggest that PKC-{theta} is critical for triggering the degradation of Cbl-b that is necessary to enable a full immune response in T cells.

Citation: T. Gruber, N. Hermann-Kleiter, R. Hinterleitner, F. Fresser, R. Schneider, G. Gastl, J. M. Penninger, G. Baier, PKC-{theta} Modulates the Strength of T Cell Responses by Targeting Cbl-b for Ubiquitination and Degradation. Sci. Signal. 2, ra30 (2009).

Read the Full Text

Cbl-b mediates TGF{beta} sensitivity by downregulating inhibitory SMAD7 in primary T cells.
T. Gruber, R. Hinterleitner, N. Hermann-Kleiter, M. Meisel, I. Kleiter, C. M. Wang, A. Viola, C. Pfeifhofer-Obermair, and G. Baier (2013)
J Mol Cell Biol 5, 358-368
   Abstract »    Full Text »    PDF »
Cbl-b Is a Critical Regulator of Macrophage Activation Associated With Obesity-Induced Insulin Resistance in Mice.
T. Abe, K. Hirasaka, S. Kagawa, S. Kohno, A. Ochi, K. Utsunomiya, A. Sakai, A. Ohno, S. Teshima-Kondo, Y. Okumura, et al. (2013)
Diabetes 62, 1957-1969
   Abstract »    Full Text »    PDF »
Inhibiting the Inhibitor of the Inhibitor: Blocking PKC-{theta} to Enhance Regulatory T Cell Function.
K. T. Roybal and C. Wulfing (2010)
Science Signaling 3, pe24
   Abstract »    Full Text »    PDF »
Activation of T Cells: Releasing the Brakes by Proteolytic Elimination of Cbl-b.
M. L. Schmitz (2009)
Science Signaling 2, pe38
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882